Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats

Journal of Hepatology

Volumn 57, Issue 4, 2012, Pages 803-812

  Zhang, Hui Lu ^a   Yu, Le Xing ^a   Yang, Wen ^a   Tang, Liang ^a   Lin, Yan ^a   Wu, Han ^a   Zhai, Bo ^d   Tan, Ye Xiong ^a   Shan, Lei ^a   Liu, Qiong ^a,c   Chen, Hai Yang ^a   Dai, Rong Yang ^a,b   Qiu, Bi Jun ^d   He, Ya Qin ^a   Wang, Chao ^a   Zheng, Long Yi ^e   Li, Yu Qiong ^a   Wu, Fu Quan ^a   Li, Zhong ^a   Yan, He Xin ^a   Wang, Hong Yang ^a,b   more..

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c NAVAL MEDICAL RESEARCH INSTITUTE   (China)

^d SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^e SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Endotoxin; Gut homeostasis; Hepatocellular carcinoma; Probiotics

Indexed keywords

DEXTRAN SULFATE; DIETHYLNITROSAMINE; ENDOTOXIN; HIGH MOBILITY GROUP B1 PROTEIN; HYALURONIC ACID; INTERLEUKIN 10; INTERLEUKIN 6; KI 67 ANTIGEN; PENICILLIN G; PROBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BIFIDOBACTERIUM; BLOOD SAMPLING; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DRUG MEGADOSE; ENTERITIS; ENTEROCOCCUS; ESCHERICHIA COLI; HUMAN; INTESTINE FLORA; INTESTINE MUCOSA; LACTOBACILLUS; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; MICROBIAL COMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; TUMOR VOLUME;

ALKYLATING AGENTS; ANIMALS; ANTI-BACTERIAL AGENTS; BIFIDOBACTERIUM; CARCINOMA, HEPATOCELLULAR; CYTOKINES; DEXTRAN SULFATE; DIETHYLNITROSAMINE; DISEASE PROGRESSION; ENDOTOXINS; ENTEROCOCCUS; GASTROENTERITIS; GASTROINTESTINAL TRACT; HMGB1 PROTEIN; HOMEOSTASIS; HUMANS; LACTOBACILLUS; LIVER CIRRHOSIS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; PENICILLINS; PROBIOTICS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84866383592     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.06.011     Document Type: Article

References (35)

1. M. Karin Nuclear factor-kappaB in cancer development and progression Nature 441 2006 431 436
2. S.I. Grivennikov, F.R. Greten, and M. Karin Immunity, inflammation, and cancer Cell 140 2010 883 899
3. L.X. Yu, H.X. Yan, Q. Liu, W. Yang, H.P. Wu, and W. Dong Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents Hepatology 52 4 2010 1322 1333
4. H. Dianne, A.M. Dapito, G. Geum-Youn, P. Jean-Philippe, J. Myoung-Kuk, and M. Ingmar Promotion of Hepatocellular Carcinoma by the gut microbiota and TLR4 Cancer Cell 21 2012 504 516
5. J. Almeida, S. Galhenage, J. Yu, J. Kurtovic, and S.M. Riordan Gut flora and bacterial translocation in chronic liver disease World J Gastroenterol 12 2006 1493 1502
6. S.M. Riordan, and R. Williams The intestinal flora and bacterial infection in cirrhosis J Hepatol 45 2006 744 757
7. R. Wiest, and G. Garcia-Tsao Bacterial translocation (BT) in cirrhosis Hepatology 41 2005 422 433
8. K. Madsen, A. Cornish, P. Soper, C. McKaigney, H. Jijon, and C. Yachimec Probiotic bacteria enhance murine and human intestinal epithelial barrier function Gastroenterology 121 2001 580 591
9. A. Garcia-Lafuente, M. Antolin, F. Guarner, E. Crespo, and J.R. Malagelada Modulation of colonic barrier function by the composition of the commensal flora in the rat Gut 48 2001 503 507
10. I. Guerrero Hernandez, A. Torre Delgadillo, F. Vargas Vorackova, and M. Uribe Intestinal flora, probiotics, and cirrhosis Ann Hepatol 7 2008 120 124
11. T. Matsuki, K. Watanabe, J. Fujimoto, Y. Miyamoto, T. Takada, and K. Matsumoto Development of 16S rRNA-gene-targeted group-specific primers for the detection and identification of predominant bacteria in human feces Appl Environ Microbiol 68 2002 5445 5451
12. T. Matsuki, K. Watanabe, J. Fujimoto, T. Takada, and R. Tanaka Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces Appl Environ Microbiol 70 2004 7220 7228
13. T. Rinttila, A. Kassinen, E. Malinen, L. Krogius, and A. Palva Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR J Appl Microbiol 97 2004 1166 1177
14. A.M. Gronvold, T.M. L'Abee-Lund, H. Sorum, E. Skancke, A.C. Yannarell, and R.I. Mackie Changes in fecal microbiota of healthy dogs administered amoxicillin FEMS Microbiol Ecol 71 2010 313 326
15. T.S. Olson, B.K. Reuter, K.G. Scott, M.A. Morris, X.M. Wang, and L.N. Hancock The primary defect in experimental ileitis originates from a nonhematopoietic source J Exp Med 203 2006 541 552
16. L. Caradonna, L. Amati, T. Magrone, N.M. Pellegrino, E. Jirillo, and D. Caccavo Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance J Endotoxin Res 6 2000 205 214
17. M. Schietroma, S. Cappelli, F. Carlei, G. Di Giuro, A. Agnifili, and C.L. Recchia Intestinal and systemic endotoxaemia after laparotomic or laparoscopic cholecystectomy Chir Ital 58 2006 171 177
18. J. Wyatt, H. Vogelsang, W. Hubl, T. Waldhoer, and H. Lochs Intestinal permeability and the prediction of relapse in Crohn's disease Lancet 341 1993 1437 1439
19. D.C. Savage, and R. Dubos Alterations in the mouse cecum and its flora produced by antibacterial drugs J Exp Med 128 1968 97 110
20. E. Gaudio, G. Taddei, A. Vetuschi, R. Sferra, G. Frieri, and G. Ricciardi Dextran sulfate sodium (DSS) colitis in rats: clinical, structural, and ultrastructural aspects Dig Dis Sci 44 1999 1458 1475
21. J.M. Uronis, J.C. Arthur, T. Keku, A. Fodor, I.M. Carroll, and M.L. Cruz Gut microbial diversity is reduced by the probiotic VSL#3 and correlates with decreased TNBS-induced colitis Inflamm Bowel Dis 17 2011 289 297
22. R.M. Patel, and P.W. Lin Developmental biology of gut-probiotic interaction Gut Microbes 1 2010 186 195
23. C. Pagnini, R. Saeed, G. Bamias, K.O. Arseneau, T.T. Pizarro, and F. Cominelli Probiotics promote gut health through stimulation of epithelial innate immunity Proc Natl Acad Sci USA 107 2010 454 459
24. S.L. Gorbach, M. Barza, M. Giuliano, and N.V. Jacobus Colonization resistance of the human intestinal microflora: testing the hypothesis in normal volunteers Eur J Clin Microbiol Infect Dis 7 1988 98 102
25. P.A. Farazi, and R.A. DePinho Hepatocellular carcinoma pathogenesis: from genes to environment Nat Rev Cancer 6 2006 674 687
26. W.E. Naugler, T. Sakurai, S. Kim, S. Maeda, K. Kim, and A.M. Elsharkawy Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production Science 317 2007 121 124
27. S. Kakumu, A. Fukatsu, T. Shinagawa, S. Kurokawa, and A. Kusakabe Localisation of intrahepatic interleukin 6 in patients with acute and chronic liver disease J Clin Pathol 45 1992 408 411
28. M. Howard, T. Muchamuel, S. Andrade, and S. Menon Interleukin 10 protects mice from lethal endotoxemia J Exp Med 177 1993 1205 1208
29. P.A. Knolle, E. Loser, U. Protzer, R. Duchmann, and E. Schmitt Zum Buschenfelde KH et al. Regulation of endotoxin-induced IL-6 production in liver sinusoidal endothelial cells and Kupffer cells by IL-10 Clin Exp Immunol 107 1997 555 561
30. C. Di Giacinto, M. Marinaro, M. Sanchez, W. Strober, and M. Boirivant Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells J Immunol 174 2005 3237 3246
31. I.N. Crispe The liver as a lymphoid organ Annu Rev Immunol 27 2009 147 163
32. A. Mencin, J. Kluwe, and R.F. Schwabe Toll-like receptors as targets in chronic liver diseases Gut 58 2009 704 720
33. P. Scaffidi, T. Misteli, and M.E. Bianchi Release of chromatin protein HMGB1 by necrotic cells triggers inflammation Nature 418 2002 191 195
34. A. Liu, O. Dirsch, H. Fang, W. Dong, H. Jin, and H. Huang HMGB1 translocation and expression is caused by warm ischemia reperfusion injury, but not by partial hepatectomy in rats Exp Mol Pathol 91 2011 502 508
35. A. Tsung, J.R. Klune, X. Zhang, G. Jeyabalan, Z. Cao, and X. Peng HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling J Exp Med 204 2007 2913 2923